Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in ALD [225,226] and NAFLD as well [36,51,225,227]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.